Bristol-Myers Squibb Company (BMY)

Global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases.

BMY Stock Quote

Company Report

Bristol-Myers Squibb Company is a global biopharmaceutical leader engaged in the discovery, development, licensing, manufacturing, and marketing of innovative medicines. With a diverse portfolio spanning hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and COVID-19 diseases, the company is dedicated to addressing critical medical needs worldwide. Key products include Revlimid for multiple myeloma, Eliquis for stroke prevention and DVT/PE treatment, Opdivo for anti-cancer therapy, and Pomalyst/Imnovid for multiple myeloma patients.

Additionally, Bristol-Myers Squibb offers a range of treatments such as Orencia for rheumatoid arthritis, Sprycel for chronic myeloid leukemia, Yervoy for melanoma, and Abraxane for chemotherapy. The company's innovative pipeline includes Reblozyl for beta thalassemia-related anemia, Empliciti for multiple myeloma, Zeposia for multiple sclerosis, Breyanzi for large B-cell lymphoma, Inrebic for myelofibrosis, and Onureg for acute myeloid leukemia.

Founded in 1887 and headquartered in New York, New York, Bristol-Myers Squibb serves a broad customer base including wholesalers, distributors, pharmacies, hospitals, clinics, retailers, and government agencies. Formerly known as Bristol-Myers Company, the company's commitment to advancing healthcare through groundbreaking therapies underscores its position as a leader in the biopharmaceutical industry, continuously striving to improve patient outcomes worldwide.

BMY EPS Chart

BMY Revenue Chart

Stock Research

POWL PLUS RHP ELSE NUVL ECO LADR

BMY Chart

View interactive chart for BMY

BMY Profile

BMY News

Analyst Ratings